Enlife Raises Rs 6 Crore to Develop AI-Based Blood Test for Early Alzheimer's Detection
Bengaluru-based deeptech startup Enlife Research has raised Rs 6 crore led by Piper Serica to develop an AI-powered blood test for early Alzheimer's detection tailored to the Indian population. Founded by Dr Deepak Kumaran Nair and colleagues, the platform aims to replace costly, invasive scans by detecting the disease up to 15 years in advance. Funds will support validation, research expansion, and clinical-grade assay development to improve accessibility and affordability in India.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (75/100). Lens Score 38/100 — moderate-to-low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- economictimes— balanced framing, positive sentiment
- economictimes— balanced framing, positive sentiment
AI Analysis
The articles present a neutral, innovation-focused perspective emphasizing technological advancement and healthcare accessibility in India. They highlight the startup's efforts without political framing, focusing on scientific development and funding. No partisan viewpoints or political interpretations are evident, reflecting a straightforward business and health technology narrative.
The tone across the articles is positive, highlighting progress in medical technology and potential benefits for early Alzheimer's diagnosis. The coverage emphasizes hope and innovation without exaggeration, maintaining an optimistic yet factual approach to the startup's funding and goals.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.